Kuebart Anne, Wollborn Verena, Huhn Ragnar, Hermanns Henning, Werdehausen Robert, Brandenburger Timo
Department of Anesthesiology, University Hospital Düsseldorf, Medical Faculty, Düsseldorf 40225, Germany.
Department of Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
J Pain Res. 2020 Nov 13;13:2907-2914. doi: 10.2147/JPR.S266937. eCollection 2020.
Alterations of the expression of microRNAs (miRNAs) in chronic pain models seem to play a crucial role in the development of neuropathic pain, with microRNA-1 (miR-1) being of particular interest. Recently, we were able to show that decreased miR-1 levels were associated with increased expression of brain-derived neurotrophic factor (BDNF) and Connexin 43 (Cx43). We hypothesized that miR-1 mimetic nucleotides could alleviate neuropathic pain caused by chronic constriction injury in rats.
MiR-1 mimetic nucleotides were evaluated for effectiveness, functionality, and intracellular stability by transfecting human glioblastoma cells (U-87 MG). In vivo transfection with miR-1 mimics and corresponding scrambled miRNAs serving as control was performed by repetitive injection (days 0, 3, and 7) into the sciatic nerve following chronic constriction injury (CCI) in rats. Quantitative PCR was used to measure miR-1 content. Cx43 expression was determined by Western blot analysis. Effects on neuropathic pain were assessed by detecting paw withdrawal thresholds using an automated filament application.
Transfection of miR-1 mimics was confirmed in U-87 MG cells, with miR-1 content being increased significantly after 48 h and after 96 h (p<0.05). Effective downregulation of Cx43 expression was observed 48 and 96 h after transfection (-44 ± 0.07% and -40 ± 0.11%; p<0.05). In vivo, repetitive transfection with miR-1 mimetic nucleotides led to a 17.9-fold (± 14.2) increase of miR-1 in the sciatic nerve. However, the protein expression of Cx43 in sciatic nerves as well as paw withdrawal thresholds for mechanical stimulation was not significantly increased 10 days after chronic constriction injury.
While transfection with miR-1 mimics effective reduces Cx43 expression in vitro and restores miR-1 after CCI, we did neither observe altered levels of Cx43 protein level in nerves nor a beneficial effect on mechanical allodynia in vivo, most likely caused by insufficient Cx43 suppression.
慢性疼痛模型中微小RNA(miRNA)表达的改变似乎在神经性疼痛的发展中起关键作用,其中微小RNA - 1(miR - 1)尤为引人关注。最近,我们发现miR - 1水平降低与脑源性神经营养因子(BDNF)和连接蛋白43(Cx43)表达增加有关。我们推测miR - 1模拟核苷酸可以减轻大鼠慢性压迫性损伤所致的神经性疼痛。
通过转染人胶质母细胞瘤细胞(U - 87 MG)评估miR - 1模拟核苷酸的有效性、功能和细胞内稳定性。在大鼠慢性压迫性损伤(CCI)后,通过向坐骨神经重复注射(第0、3和7天)miR - 1模拟物和相应的作为对照的乱序miRNA进行体内转染。采用定量PCR检测miR - 1含量。通过蛋白质印迹分析确定Cx43表达。使用自动纤维施加器检测爪退缩阈值来评估对神经性疼痛的影响。
在U - 87 MG细胞中转染miR - 1模拟物得到证实,48小时和96小时后miR - 1含量显著增加(p<0.05)。转染后48小时和96小时观察到Cx43表达有效下调(-44±0.07%和-40±0.11%;p<0.05)。在体内,用miR - 1模拟核苷酸重复转染导致坐骨神经中miR - 1增加17.9倍(±14.2)。然而,慢性压迫性损伤10天后,坐骨神经中Cx43的蛋白表达以及机械刺激的爪退缩阈值并未显著增加。
虽然用miR - 1模拟物转染在体外有效降低Cx43表达并在CCI后恢复miR - 1,但我们在体内既未观察到神经中Cx43蛋白水平的改变,也未观察到对机械性异常性疼痛的有益作用,这很可能是由于Cx43抑制不足所致。